MeiraGTx Holdings (MGTX) Stock Highlights

6.15 | +5.31%

2024-12-21 05:22:46

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The companys pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union.

Statistics

Range Today

5.66 6.48

Volume Today 1.2M

Range 1 Year

3.85 7.6

Volume 1 Year 55.46M

Range 3 Year

3.49 24.9

Volume 3 Year 144.44M

Range 10 Year

3.49 30.23

Volume 10 Year 272.18M

Highlights

Market Capitalization 534.12M (small)

Floating Shares 25.09M

Current Price 6.15

Price To Earnings -4.82

Price To Revenue 53.77

Price To Book 5.59

Earnings Per Share -1.42

Payout Ratio 0%

Performance

Latest +5.31%

1 Month +3.71%

3 Months +41.38%

6 Months +46.08%

1 Year +23.99%

3 Years -69.66%

5 Years -71.38%

10 Years -59.03%

Benchmarks

Market Capitalization

183 / 368

Gross Profits

89 / 278

Total Revenue

195 / 300

Total Rank

334 / 368

Free Cashflow

232 / 352

Performance 5 years

207 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.